Ładuje się......
Prostanoids in Asthma and COPD: Actions, Dysregulation, and Therapeutic Opportunities
Pathophysiologic gaps in the actions of currently available treatments for asthma and COPD include neutrophilic inflammation, airway remodeling, and alveolar destruction. All of these processes can be modulated by cyclic adenosine monophosphate-elevating prostaglandins E(2) and I(2) (also known as p...
Zapisane w:
| Wydane w: | Chest |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American College of Chest Physicians
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4631042/ https://ncbi.nlm.nih.gov/pubmed/26204554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.15-1029 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|